Surgery Partners (SGRY) Technical (Analysis) Reports Surgery Partners ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Surgery Partners (SGRY)
Technical Analysis Report for NASDAQ stock SGRY Surgery Partners. Dated: 09 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Hospital Nursing Management in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock SGRY Surgery Partners then click here. or read Experts views on Surgery Partners or Forecast & share price targets of Surgery Partners
Surgery Partners Opened at 13.43 and Closed at: 13.48, which is -0.59% of previous session's close. It moved within a range of 13.14 and 13.63
The session was a Bullish session with an average volume of 1032800, which is -18.69% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
A Dead cross was found 9 days back on short term averages
Support for tomorrow is 13.31 and resistance for tomorrow is 13.8
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 13.2, 12.93 resistance for tomorrow's hourly charts is 13.69, 13.91
10 Day SMA for Surgery Partners (SGRY) is 14.3 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Surgery Partners (SGRY) is 15.1 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Surgery Partners (SGRY) is 15.71 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 17.9 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Surgery Partners is 20.17 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Surgery Partners is at 15.1 and 200 DMA is at 20.17, while 50 DMA and 100 DMA are at 15.71 and 17.9 respectively
Surgery Partners (SGRY) moving average of 20 SMA is at 15.1 and 20 EMA is at 14.79
| Date | Closing Price | 20 SMA | 20 EMA |
| 09 Mon Feb | 13.48 | 15.1 | 14.79 |
| 06 Fri Feb | 13.56 | 15.23 | 14.93 |
| 05 Thu Feb | 13.43 | 15.34 | 15.07 |
| 04 Wed Feb | 14.05 | 15.45 | 15.24 |
| 03 Tue Feb | 14.22 | 15.52 | 15.36 |
| 02 Mon Feb | 14.80 | 15.58 | 15.48 |
Surgery Partners (SGRY) moving average of 50 SMA is at 15.71 and 50 EMA is at 15.84
| Date | Closing Price | 50 SMA | 50 EMA |
| 09 Mon Feb | 13.48 | 15.71 | 15.84 |
| 06 Fri Feb | 13.56 | 15.78 | 15.94 |
| 05 Thu Feb | 13.43 | 15.83 | 16.04 |
| 04 Wed Feb | 14.05 | 15.88 | 16.15 |
| 03 Tue Feb | 14.22 | 15.91 | 16.24 |
| 02 Mon Feb | 14.80 | 15.94 | 16.32 |
Surgery Partners (SGRY) moving average of 100 SMA is at 17.9 and 100 EMA is at 17.4
| Date | Closing Price | 100 SMA | 100 EMA |
| 09 Mon Feb | 13.48 | 17.9 | 17.4 |
| 06 Fri Feb | 13.56 | 17.98 | 17.48 |
| 05 Thu Feb | 13.43 | 18.06 | 17.56 |
| 04 Wed Feb | 14.05 | 18.15 | 17.64 |
| 03 Tue Feb | 14.22 | 18.23 | 17.71 |
| 02 Mon Feb | 14.80 | 18.3 | 17.78 |
Surgery Partners (SGRY) moving average of 200 SMA is at 20.17 and 200 EMA is at 19.64
| Date | Closing Price | 200 SMA | 200 EMA |
| 09 Mon Feb | 13.48 | 20.17 | 19.64 |
| 06 Fri Feb | 13.56 | 20.2 | 19.7 |
| 05 Thu Feb | 13.43 | 20.24 | 19.76 |
| 04 Wed Feb | 14.05 | 20.28 | 19.82 |
| 03 Tue Feb | 14.22 | 20.31 | 19.88 |
| 02 Mon Feb | 14.80 | 20.35 | 19.94 |
Xoma Corporation has performed better than Surgery Partners in short term. You could have earned much better returns by investing in Xoma Corporation, about 5.48% more returns!
Veracyte Inc has performed better than Surgery Partners in short term. You could have earned much better returns by investing in Veracyte Inc, about 1.73% more returns!
Tg Therapeutics has performed better than Surgery Partners in short term. You could have earned much better returns by investing in Tg Therapeutics, about 24.03% more returns!
Surgery Partners has performed better than Staar Surgical in short term. Holding Surgery Partners could be a better choice for now!
Syndax Pharmaceuticals has performed better than Surgery Partners in short term. You could have earned much better returns by investing in Syndax Pharmaceuticals, about 19.27% more returns!
Si Bone has performed better than Surgery Partners in short term. You could have earned much better returns by investing in Si Bone, about 3.32% more returns!
Ultragenyx Pharmaceutical has performed better than Surgery Partners in short term. You could have earned much better returns by investing in Ultragenyx Pharmaceutical, about 15.19% more returns!
Nektar Therapeutics has performed better than Surgery Partners in short term. You could have earned much better returns by investing in Nektar Therapeutics, about 12.82% more returns!
Adma Biologics has performed better than Surgery Partners in short term. You could have earned much better returns by investing in Adma Biologics, about 8.5% more returns!
Assembly Biosciences has performed better than Surgery Partners in short term. You could have earned much better returns by investing in Assembly Biosciences, about 4.17% more returns!
Ascendis Pharma has performed better than Surgery Partners in short term. You could have earned much better returns by investing in Ascendis Pharma, about 23.56% more returns!
Surgery Partners has performed better than Alphatec Holdings in short term. Holding Surgery Partners could be a better choice for now!
Axsome Therapeutics has performed better than Surgery Partners in short term. You could have earned much better returns by investing in Axsome Therapeutics, about 20.82% more returns!
Biolife Solutions has performed better than Surgery Partners in short term. You could have earned much better returns by investing in Biolife Solutions, about 11.33% more returns!
Corbus Pharmaceuticals has performed better than Surgery Partners in short term. You could have earned much better returns by investing in Corbus Pharmaceuticals, about 16.08% more returns!
Enanta Pharmaceuticals has performed better than Surgery Partners in short term. You could have earned much better returns by investing in Enanta Pharmaceuticals, about 24.33% more returns!
Eton Pharmaceuticals has performed better than Surgery Partners in short term. You could have earned much better returns by investing in Eton Pharmaceuticals, about 12.87% more returns!
Surgery Partners has performed better than Fulgent Genetics in short term. Holding Surgery Partners could be a better choice for now!
Surgery Partners Technical analysis of indicators
Price action analysis of Surgery Partners (SGRY) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Surgery Partners stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Surgery Partners in short term and the sell signal is strong.
Surgery Partners Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Surgery Partners in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Surgery Partners is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 14.29 and Surgery Partners SGRY stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Surgery Partners SGRY stock. Volume based technical analysis of Surgery Partners SGRY stock is negative.
Surgery Partners Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock SGRY Surgery Partners These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And SGRY Experts View which covers a lot of information including buying and selling signals
SGRY future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Surgery Partners or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Surgery Partners (SGRY) Technical (Analysis) Reports Surgery Partners ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


